Masaru Tanaka, MD Dr. Masaru Tanaka graduated in 1984 at the Keio University School of Medicine, in Tokyo/Japan. Board certified dermatologist since 1989 and obtained degree of doctor in Medical Science in 1992. He studied image analysis at Department of Dermatology, University of Wales College of Medicine, in Cardiff/UK for two years (1993-1995). Associate Professor (1999-2005) of Dermatology at the Keio University. Dr. Tanaka was the Congress Secretary of the 100th Japanese Dermatolgoical Association in Tokyo in April 2001. Nowadays he is Associate Professor of Dermatology at the Department of Dermatology, Tokyo Wemen's Medical University Medical Center East, in Tokyo/Japan.
His main research field is the bullous disorders, contact dermatitis, dermatopathology, image analysis and dermoscopy.
Recent publications
Dekio I, Anzai H, Ohyama M et al. Aleukaemic leukaemia cutis as an initial manifestation of myeloid/NK cell precursor acute leukaemia. J Eur Acad Dermatol Venereol. 2006;20:453-456.
Iyatomi H, Oka H, Saito M et al. Quantitative assessment of tumor extraction from dermoscopy images and evaluation of computer-based extraction methods for automatic melanoma diagnostic system. Melanoma Res. 2006;16:183-190.
Piccolo D, Soyer HP, Chimenti S et al. Diagnosis and categorization of acral melanocytic lesions using teledermoscopy. J Telemed Telecare. 2004;10:346-350.
Takahashi H, Ishiko A, Kobayashi M, Tanikawa A, Takasu H, Tanaka M. Malignant chondroid syringoma with bone invasion: A case report and review of the literature. Am J Dermatopathol. 2004;26:403-406.
Oka H, Tanaka M, Kobayashi S, Argenziano G, Soyer HP, Nishikawa T. Linear discriminant analysis of dermoscopic parameters for differentiation of early melanomas from Clark nevi. Melanoma Research. 2004;14:131-134.
Oka H, Hashimoto M, Iyatomi H, Argenziano G, Soyer HP, Tanaka M. Internet-based program for automatic discrimination of dermoscopic images between melanomas and Clark nevi. Br J Dermatol. 2004;150:1041-1041.
Yoshida R, Wada N, Nakasute K, Saitoh H, Nagao K, Tanaka M. Dermoscopic features of mucinous carcinoma of the skin. Dermatol Surg. 2004;30:1138-1139.
Argenziano G, Soyer HP, Chimenti S et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol. 2003;48:679-693.
Piccolo D, Soyer HP, Burgdorf W et al. Concordance between telepathologic diagnosis and conventional histopathologic diagnosis: a multiobserver store-and-forward study on 20 skin specimens. Arch Dermatol. 2002;138:53-58.
Tanaka M, Kobayashi S, Murata T, Tanikawa A, Nishikawa T. Allergic contact dermatitis due to diethyl sebacate in lanoconazole cream. Contact Dermatitis. 2000;43:233-234.
Piccolo D, Smolle J, Argenziano G et al. Teledermoscopy - results of a multicentre study on 43 pigmented skin lesions. J Telemed Telecare. 2000;6:132-137.
Tanaka M, Gaskell SA, Edwards C, Marks R. Simple horizontal averaging programme enables shade correction for image analysis in psoriasis. Clin Exp Dermatol. 2000;25:323-326. 13. Tanaka M. Minimum requirements for digital images in dermatological publications. Clin Exp Dermatol. 1999;24:427.
Tanaka M, Hashimoto T, Dykes PJ, Nishikawa T. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles. Clin Exp Dermatol. 1996;21:23-27.
Tanaka M, Niizeki H, Shimizu S, Miyakawa S. Photoallergic drug eruption due to pyridoxine hydrochloride. J Dermatol. 1996;23:708-709.
Shimizu S, Tanaka M, Niizeki H, Miyakawa S, Ishiko A, Shimizu H. Classic (non-AIDS-related) Kaposi's sarcoma in a Japanese patient, successfully treated with alpha-2b-interferon. Br J Dermatol. 1995;133:332-334.
Tanaka M, Niizeki H, Miyakawa S. Contact dermatitis from epsilon-aminocaproic acid. Contact Dermatitis. 1993;28:124.
Tanaka M, Kobayashi S, Miyakawa S. Contact dermatitis from nylon 6 in Japan. Contact Dermatitis. 1993;28:250.
Tanaka M, Shimizu S, Miyakawa S. Contact dermatitis from glyceryl diisostearate. Contact Dermatitis. 1993;29:41-42.
Tanaka M, Hashimoto T, Amagai M et al. Characterization of bullous pemphigoid antibodies by use of recombinant bullous pemphigoid antigen proteins. J Invest Dermatol. 1991;97:725-728.